Search
Close this search box.
Trans-Tasman Radiation Oncology Group, Home, TROG Cancer Research
Trans-Tasman Radiation Oncology Group, Home, TROG Cancer Research

Trans Tasman Radiation Oncology Group is one of the largest cancer clinical trials groups in Australia and New Zealand.

Over three decades, the Trans Tasman Radiation Oncology Group (TROG) has facilitated more than 100 clinical trials that have helped improve the quality of life and treatment options for almost 15,000 volunteer cancer patients. 

During that time, the prognosis of cancer patients has improved considerably. In the 1980s the cancer survival rate was less than 50 per cent. Today, for some cancers, the survival rate is as high as 90 per cent.

TROG Cancer Research is focused on radiation treatment, for the many types of cancers it can treat.

Conducting clinical trials for many types of cancer

Our upcoming, current, and past clinical trials have investigated the effectiveness of radiation therapy in treating the following groups of cancers. Our members have also investigated the impact of radiation therapy on symptom management and palliative care.

Bladder, Kidney & Prostate Cancers

Read about many innovative TROG trials shedding light on management of Bladder, Kidney & Prostate Cancers.

Brain & Central Nervous System Cancers

Learn more about how TROG contributes to evidence about treating Brain & Central Nervous System Cancers.

Breast Cancer

See how we contribute to a greater understanding of effective treatments for breast cancer patients.

Gastrointestinal Cancer

Understand how TROG contributes to gastrointestinal cancer trials. including in Gastric, Oesophageal & Pancreatic Cancers.

Head & Neck Cancer

Read about our wide-ranging research to improve management and outcomes in Head & Neck Cancers.

Gynaecological Cancer

View our clinical trials to treat Gynaecolgoical Cancers including Endometrial & Cervical Cancer.

Lung Cancer

Discover our research to progress Lung Cancer treatments and outcomes.

Lymphomas

See how we contribute to a broader understanding of effective treatments for lymphoma cancer patients.

Skin Cancer

Find out about our clinical trials across a range of different Skin Cancers including Melanoma & Squamous Cell Carcinoma.

Research that has an impact

Trans-Tasman Radiation Oncology Group, Home, TROG Cancer Research
Trans-Tasman Radiation Oncology Group, Home, TROG Cancer Research

The TOPGEAR trial: shedding light on gastric cancer treatments

Sebastian's Story

For Sebastian, who was diagnosed with stomach cancer at the age of 38, taking part in a clinical trial to help determine the best treatment options not only helped him exhaust all avenues on his cancer journey, but was an opportunity to contribute to scientific knowledge that is helping other patients today.

Trans-Tasman Radiation Oncology Group, Home, TROG Cancer Research

Register for the 2025 ASM

Radiation Therapy Quality Assurance program

Patients who choose to be part of a cancer clinical trial can be assured that patient safety and radiation therapy protocol compliance is stringently monitored under the TROG Cancer Research Radiation Therapy Quality Assurance (RTQA) program.

As new technologies and techniques are incorporated into radiation therapy treatment, RTQA develops robust radiation therapy planning, delivery, and quality assurance guidelines that ensure compliance and trial quality.

We invite you to explore the cancer clinical trials projects and people leading the fight to cure all cancers with one treatment.

Trans-Tasman Radiation Oncology Group, Home, TROG Cancer Research

Not yet a TROG Cancer Research member? Join now

Full membership to the Trans-Tasman Radiation Oncology Group (TROG) is open to anyone qualified in their discipline. This includes Radiation Oncologists, Medical Oncologists, Radiation Therapists, Medical Physicists, Statisticians, Data Managers, Nurses, and Surgeons. 

Affiliate membership is also available to anyone qualified or training in a radiation therapy-related discipline. For full details, visit our membership page.

Industry Blog & News